Virax Biolabs Group Ltd - Ordinary shares, par value $0.001 per share (VRAX)

CUSIP: G9495L125

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Ordinary shares, par value $0.001 per share
Shares outstanding
8,247,337
Total 13F shares
63,007
Share change
-158,063
Total reported value
$141,366
Price per share
$2.25
Number of holders
7
Value change
-$294,712
Number of buys
6
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP G9495L125?
CUSIP G9495L125 identifies VRAX - Virax Biolabs Group Ltd - Ordinary shares, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Virax Biolabs Group Ltd - Ordinary shares, par value $0.001 per share (VRAX) as of Q4 2024

As of 31 Dec 2024, Virax Biolabs Group Ltd - Ordinary shares, par value $0.001 per share (VRAX) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 63,007 shares. The largest 7 holders included UBS Group AG, XTX Topco Ltd, Royal Bank of Canada, R Squared Ltd, MORGAN STANLEY, NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO, and Tower Research Capital LLC (TRC). This page lists 7 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.